Xiadafil VIP Tablets Seized By FDA After Company Refuses to Recall Product

At the request of the U.S. Food and Drug Administration, U.S. Marshals seized nearly $74,000 worth of Xiadafil VIP tablets, Lots 6K029 and 6K209-SEI, distributed by SEI Pharmaceuticals, Inc. of Miami, Fla.

FDA Requests Recall of Xiadafil VIP Tabs

The U.S. Food and Drug Administration today requested that SEI Pharmaceuticals, of Miami, Fla., recall all Xiadafil VIP Tabs sold in 8 tablet bottles (Lot # 6K029) or blister cards of 2 tablets (Lot # 6K029-SEI) because these products contain a potentially...

Federal Authorities Seize More Than $100,000 of Unapproved Drugs Marketed As “Natural Supplements”

At the request of the U.S. Food and Drug Administration, today U.S. Marshals seized more than 14,000 dosage units of Shangai Regular, Shangai Ultra, Super Shangai, Naturalë Super Plus, and Lady Shangai.

FDA Warns Consumers Not to Use “Blue Steel” And “Hero” Products

The U.S. Food and Drug Administration is advising consumers not to purchase or use “Blue Steel” or “Hero” products marketed as dietary supplements throughout the United States because they are considered unapproved drugs and have...